Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide [NA]

View source ↗

Summary

A clinical trial in Denmark is evaluating whether calcitonin gene-related peptide can induce migraine attacks with aura; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CGRP (Calcitonin gene-related peptide)

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine Aura, Migraine With Aura | NA | Status: RECRUITING